• 1. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 2. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 3. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 4. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 5. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Tertiary amines

Introduction to 2-Chloro-4-(piperidin-1-yl)pyrimidine (CAS No. 5429-00-5)

2-Chloro-4-(piperidin-1-yl)pyrimidine, with the CAS number 5429-00-5, is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is a derivative of pyrimidine, a six-membered heterocyclic aromatic organic compound, and features a chlorine atom and a piperidine ring attached to the pyrimidine core. The unique structural properties of 2-Chloro-4-(piperidin-1-yl)pyrimidine make it an attractive candidate for various applications, particularly in the development of novel therapeutic agents.

The chemical structure of 2-Chloro-4-(piperidin-1-yl)pyrimidine consists of a pyrimidine ring with a chlorine substituent at the 2-position and a piperidine ring at the 4-position. This arrangement provides the molecule with distinct electronic and steric properties, which can influence its biological activity and pharmacological profile. The presence of the chlorine atom enhances the lipophilicity of the molecule, facilitating its ability to cross cell membranes and interact with biological targets. Meanwhile, the piperidine ring contributes to the molecule's basicity and can form hydrogen bonds with target proteins, enhancing its binding affinity.

In recent years, 2-Chloro-4-(piperidin-1-yl)pyrimidine has been extensively studied for its potential as a lead compound in drug discovery. One of the key areas of research has been its use as a scaffold for developing inhibitors of various kinases, which are enzymes involved in numerous cellular processes, including signal transduction and cell cycle regulation. Kinase inhibitors have shown promise in treating various diseases, particularly cancers, where aberrant kinase activity is often observed.

A notable example of the application of 2-Chloro-4-(piperidin-1-yl)pyrimidine in kinase inhibition is its use as a starting point for developing inhibitors of cyclin-dependent kinases (CDKs). CDKs are a family of serine/threonine kinases that play crucial roles in cell cycle progression and transcriptional regulation. Dysregulation of CDKs has been implicated in several cancers, making them attractive targets for therapeutic intervention. Studies have shown that derivatives of 2-Chloro-4-(piperidin-1-yl)pyrimidine can effectively inhibit CDKs, leading to cell cycle arrest and apoptosis in cancer cells.

Beyond kinase inhibition, 2-Chloro-4-(piperidin-1-yl)pyrimidine has also been explored for its potential as an antiviral agent. Research has demonstrated that certain derivatives of this compound can inhibit viral replication by interfering with essential viral enzymes or by modulating host cell pathways that are critical for viral infection. For instance, studies have shown that modified forms of 2-Chloro-4-(piperidin-1-yl)pyrimidine can inhibit the replication of human immunodeficiency virus (HIV) by targeting viral reverse transcriptase or integrase enzymes.

The synthetic accessibility of 2-Chloro-4-(piperidin-1-yl)pyrimidine is another factor that contributes to its appeal in drug discovery. Various synthetic routes have been developed to efficiently produce this compound and its derivatives. One common approach involves the reaction of 2-chloropyrimidine with piperidine under suitable conditions, such as heating or using a base catalyst. The versatility of these synthetic methods allows researchers to introduce additional functional groups or modifications to optimize the pharmacological properties of the final product.

In addition to its direct applications as a therapeutic agent, 2-Chloro-4-(piperidin-1-yl)pyrimidine serves as an important intermediate in the synthesis of more complex molecules. Its reactivity and structural flexibility make it a valuable building block for constructing libraries of compounds for high-throughput screening (HTS). HTS is a widely used technique in drug discovery that involves testing large numbers of compounds against specific biological targets to identify potential leads. By using 2-Chloro-4-(piperidin-1-yl)pyrimidine as a starting point, researchers can rapidly generate diverse chemical libraries with varying functional groups and substituents, increasing the likelihood of discovering novel bioactive compounds.

The safety profile of 2-Chloro-4-(piperidin-1-yl)pyrimidine is another important consideration in its development as a pharmaceutical agent. Preclinical studies have generally shown that this compound exhibits low toxicity and good pharmacokinetic properties, making it suitable for further evaluation in clinical trials. However, ongoing research is necessary to fully understand its safety profile and potential side effects in humans.

In conclusion, 2-Chloro-4-(piperidin-1-yl)pyrimidine (CAS No. 5429-00-5) is a promising compound with diverse applications in medicinal chemistry and pharmaceutical research. Its unique structural features and synthetic accessibility make it an attractive starting point for developing novel therapeutic agents targeting various diseases, including cancers and viral infections. As research continues to advance our understanding of this compound's properties and potential uses, it is likely to play an increasingly important role in drug discovery and development.

• 876144-87-5(1-(2-chloropyrimidin-4-yl)piperidin-4-ylmethanamine)
• 1420874-27-6((1-(2-Chloropyrimidin-4-yl)piperidin-4-yl)methanamine hydrochloride)
• 141924-04-1(1H-Azepine,1-(2-chloro-4-pyrimidinyl)hexahydro-)
• 1420846-36-1((1-(2-Chloropyrimidin-4-yl)piperidin-2-yl)methanamine hydrochloride)
• 1421020-25-8(2-Chloro-N-methyl-N-[(3R)-piperidin-3-yl]pyrimidin-4-amine;hydrochloride)
• 94222-07-8(1-(2-Chloropyrimidin-4-yl)-4-piperidinol)
• 1261231-36-0((2-Chloro-pyrimidin-4-yl)-methyl-piperidin-4-yl-amine hydrochloride)
• 1289387-24-1(1-(2-Chloropyrimidin-4-yl)-N-methylpiperidin-3-amine hydrochloride)
• 1247792-79-5(2-chloro-4-(2-methyl-1-piperidinyl)Pyrimidine)
• 35691-20-4(2-Chloro-4-(pyrrolidin-1-yl)pyrimidine)